Northwestern Mutual Wealth Management Co. Has $102,000 Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Northwestern Mutual Wealth Management Co. grew its position in Teleflex Incorporated (NYSE:TFXFree Report) by 19.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 484 shares of the medical technology company’s stock after acquiring an additional 80 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Teleflex were worth $102,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Riverview Trust Co bought a new position in Teleflex in the first quarter valued at about $31,000. Pineridge Advisors LLC bought a new stake in shares of Teleflex in the 4th quarter valued at $35,000. Canada Pension Plan Investment Board acquired a new stake in shares of Teleflex during the second quarter worth about $42,000. Versant Capital Management Inc raised its holdings in Teleflex by 20,700.0% during the 2nd quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock worth $44,000 after buying an additional 207 shares during the period. Finally, Blue Trust Inc. boosted its holdings in shares of Teleflex by 78.2% in the second quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock valued at $48,000 after buying an additional 93 shares during the period. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on TFX shares. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $205.00 to $245.00 in a report on Monday, July 1st. Royal Bank of Canada boosted their price target on Teleflex from $260.00 to $275.00 and gave the stock an “outperform” rating in a research report on Tuesday. Truist Financial raised their price objective on Teleflex from $240.00 to $247.00 and gave the company a “hold” rating in a research report on Monday, August 5th. Finally, Stephens lifted their target price on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $267.71.

Get Our Latest Research Report on TFX

Insider Activity

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the sale, the director now directly owns 5,496 shares in the company, valued at approximately $1,313,159.28. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.43% of the stock is currently owned by company insiders.

Teleflex Stock Up 0.6 %

Shares of NYSE TFX opened at $236.03 on Friday. The company’s 50 day moving average price is $240.21 and its 200-day moving average price is $222.39. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 2.58. Teleflex Incorporated has a 52-week low of $177.63 and a 52-week high of $257.85. The company has a market capitalization of $11.12 billion, a P/E ratio of 37.89, a price-to-earnings-growth ratio of 2.13 and a beta of 1.16.

Teleflex (NYSE:TFXGet Free Report) last issued its quarterly earnings results on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, beating analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The business had revenue of $749.70 million for the quarter, compared to analysts’ expectations of $762.98 million. During the same quarter in the prior year, the firm posted $3.41 earnings per share. The business’s quarterly revenue was up .9% compared to the same quarter last year. Equities analysts forecast that Teleflex Incorporated will post 13.97 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.58%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is 21.83%.

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Recommended Stories

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.